Meeder Advisory Services, Inc.

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1792167 DUBLIN, OH

Position in VRTX

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$3,186,522

+$419,314 QoQ

Shares Held

6,415

+3.5% QoQ

Ownership

0.003%

of shares outstanding

% of Portfolio

0.18%

of 13F equity value

Holder Rank

#562

of 1,730 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Meeder Advisory Services, Inc. holds $10,646,226 across 17 Biotechnology names. VRTX ranks #1 (29.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma This page	6,415	$3,186,522
2	RPRX	Royalty Pharma plc	19,242	$1,078,898
3	REGN	Regeneron Pharmaceuticals, Inc.	1,311	$817,460
4	RVMD	Revolution Medicines, Inc.	3,922	$734,512
5	IONS	Ionis Pharmaceuticals Inc	7,660	$607,361
6	MRNA	Moderna, Inc.	7,734	$541,612
7	ALNY	Alnylam Pharmaceuticals, Inc.	1,611	$484,959
8	PCVX	Vaxcyte, Inc.	7,785	$452,542

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,186,522	6,415	+3.5%	Shares	Sole	2026-08-07
2026-03-31	$2,767,208	6,197	+2.2%	Shares	Sole	2026-05-07
2025-12-31	$2,749,628	6,065	+2.6%	Shares	Sole	2026-02-11
2025-09-30	$2,315,375	5,912	-4.3%	Shares	Sole	2025-10-24
2025-06-30	$2,749,555	6,176	-2.9%	Shares	Sole	2025-08-07
2025-03-31	$3,083,455	6,360	+13.4%	Shares	Sole	2025-05-07
2024-12-31	$2,257,938	5,607	-0.5%	Shares	Sole	2025-02-12
2024-09-30	$2,620,260	5,634	+1.1%	Shares	Sole	2024-11-07
2024-06-30	$2,611,707	5,572	+39.4%	Shares	Sole	2024-08-08
2024-03-31	$1,671,203	3,998	+8.8%	Shares	Sole	2024-05-07
2023-12-31	$1,494,506	3,673	+4.1%	Shares	Sole	2024-01-25
2023-09-30	$1,226,478	3,527	-14.2%	Shares	Sole	2023-11-13
2023-06-30	$1,446,702	4,111	+5.3%	Shares	Sole	2023-08-11
2023-03-31	$1,230,033	3,904	+6.1%	Shares	Sole	2023-05-15
2022-12-31	$1,062,421	3,679	—	Shares	Sole	2023-02-14
No filing history on record for this holder in this stock.